[LGND] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
09-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- 262.53%
YoY- -23.14%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 33,161 43,484 56,157 29,267 29,648 14,602 15,958 12.95%
PBT -30,415 842,713 55,312 6,193 9,571 -74 2,150 -
Tax -6,284 176,376 10,033 1,114 3,694 15 53 -
NP -24,131 666,337 45,279 5,079 6,608 754 2,097 -
Tax Rate - -20.93% -18.14% -17.99% -38.60% - -2.47% -
Total Cost 57,292 -622,853 10,878 24,188 23,040 13,848 13,861 26.65%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -72.77 1,532.37 80.63 17.35 22.29 5.16 13.14 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -1.46 32.59 2.13 0.24 0.32 0.04 0.10 -
EPS Diluted -1.46 31.32 1.83 0.22 0.30 0.04 0.10 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.